Fig. 4From: Inhibition of CaMKIV relieves streptozotocin-induced diabetic neuropathic pain through regulation of HMGB1Distribution of pCaMKIV immunereactivity in different subpopulations of DRG neurons at 30 days after STZ treatment. a to i. Double-immunofluorescence staining shows the distribution of pCaMKIV immunereactivity in different subsets (PGP9.5, IB4, CGRP) of DRG neurons in rats. The images were 400 times magnification and the scale bar was 20 μmBack to article page